HEADER TRANSFERASE/TRANSFERASE INHIBITOR 30-NOV-16 5U2M TITLE CRYSTAL STRUCTURE OF HUMAN NAMPT WITH A-1293201 COMPND MOL_ID: 1; COMPND 2 MOLECULE: NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: NAMPT,PRE-B-CELL COLONY-ENHANCING FACTOR 1,PRE-B CELL- COMPND 5 ENHANCING FACTOR,VISFATIN; COMPND 6 EC: 2.4.2.12; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NAMPT, PBEF, PBEF1; SOURCE 6 EXPRESSION_SYSTEM: MAMMALIA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 40674; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: HEK 293-6E KEYWDS NAMPT INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR K.L.LONGENECKER,D.RAICH,A.V.KOREPANOVA REVDAT 5 04-OCT-23 5U2M 1 REMARK REVDAT 4 21-MAR-18 5U2M 1 REMARK REVDAT 3 22-NOV-17 5U2M 1 REMARK REVDAT 2 19-JUL-17 5U2M 1 JRNL REVDAT 1 28-JUN-17 5U2M 0 JRNL AUTH J.L.WILSBACHER,M.CHENG,D.CHENG,S.A.J.TRAMMELL,Y.SHI,J.GUO, JRNL AUTH 2 S.L.KOENIGER,P.J.KOVAR,Y.HE,S.SELVARAJU,H.R.HEYMAN, JRNL AUTH 3 B.K.SORENSEN,R.F.CLARK,T.M.HANSEN,K.L.LONGENECKER,D.RAICH, JRNL AUTH 4 A.V.KOREPANOVA,S.CEPA,D.L.TOWNE,V.C.ABRAHAM,H.TANG, JRNL AUTH 5 P.L.RICHARDSON,S.M.MCLOUGHLIN,I.BADAGNANI,M.L.CURTIN, JRNL AUTH 6 M.R.MICHAELIDES,D.MAAG,F.G.BUCHANAN,G.G.CHIANG,W.GAO, JRNL AUTH 7 S.H.ROSENBERG,C.BRENNER,C.TSE JRNL TITL DISCOVERY AND CHARACTERIZATION OF NOVEL NONSUBSTRATE AND JRNL TITL 2 SUBSTRATE NAMPT INHIBITORS. JRNL REF MOL. CANCER THER. V. 16 1236 2017 JRNL REFN ESSN 1538-8514 JRNL PMID 28468779 JRNL DOI 10.1158/1535-7163.MCT-16-0819 REMARK 2 REMARK 2 RESOLUTION. 1.89 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.89 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.67 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 87.5 REMARK 3 NUMBER OF REFLECTIONS : 73827 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.193 REMARK 3 R VALUE (WORKING SET) : 0.192 REMARK 3 FREE R VALUE : 0.220 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3689 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.000 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.89 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.94 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.23 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 6182 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2260 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5862 REMARK 3 BIN R VALUE (WORKING SET) : 0.2250 REMARK 3 BIN FREE R VALUE : 0.2540 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.18 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 320 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7422 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 84 REMARK 3 SOLVENT ATOMS : 623 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 24.66 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.09 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.52400 REMARK 3 B22 (A**2) : -3.45050 REMARK 3 B33 (A**2) : 6.97450 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.50530 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.260 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.170 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.144 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.168 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.144 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.933 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.910 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 7682 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 10416 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 2672 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 194 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 1108 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 7682 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 974 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 9547 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.08 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.46 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.58 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5U2M COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-DEC-16. REMARK 100 THE DEPOSITION ID IS D_1000225212. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 2011 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CLSI REMARK 200 BEAMLINE : 08ID-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979490 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-300 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS (VERSION MAY 1, 2016 REMARK 200 DATA SCALING SOFTWARE : AIMLESS, AUTOPROC (VERSION REMARK 200 1.1.7) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 74091 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.888 REMARK 200 RESOLUTION RANGE LOW (A) : 65.278 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 87.6 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.08100 REMARK 200 R SYM (I) : 0.08100 REMARK 200 FOR THE DATA SET : 12.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.89 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.7 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : 0.75800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 2GVJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.51 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.49 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% PEG 3350, 0.2 M AMMONIUM SULFATE, REMARK 280 AND 0.1 M HEPES, PH 7.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 53.30550 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 10070 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 31770 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -159.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 42 REMARK 465 LYS A 43 REMARK 465 THR A 44 REMARK 465 GLU A 45 REMARK 465 ASN A 46 REMARK 465 SER A 47 REMARK 465 LYS A 48 REMARK 465 LEU A 49 REMARK 465 ARG A 50 REMARK 465 LYS A 51 REMARK 465 VAL A 52 REMARK 465 LYS A 53 REMARK 465 GLU A 485 REMARK 465 LYS B 42 REMARK 465 LYS B 43 REMARK 465 THR B 44 REMARK 465 GLU B 45 REMARK 465 ASN B 46 REMARK 465 SER B 47 REMARK 465 LYS B 48 REMARK 465 LEU B 49 REMARK 465 ARG B 50 REMARK 465 LYS B 51 REMARK 465 VAL B 52 REMARK 465 LYS B 53 REMARK 465 GLU B 485 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 95 -16.20 -40.43 REMARK 500 TYR A 231 -57.17 -123.37 REMARK 500 PHE A 269 58.39 -119.06 REMARK 500 TYR A 281 -52.30 -125.06 REMARK 500 GLU A 293 -70.34 -135.05 REMARK 500 ASP A 313 26.17 -145.80 REMARK 500 ASP A 416 70.70 -150.71 REMARK 500 GLU A 451 47.80 -85.07 REMARK 500 ASN B 29 32.45 70.14 REMARK 500 TYR B 231 -55.63 -121.93 REMARK 500 PHE B 269 58.50 -119.87 REMARK 500 TYR B 281 -51.11 -128.21 REMARK 500 GLU B 293 -68.32 -132.44 REMARK 500 ASP B 313 23.34 -145.01 REMARK 500 GLU B 451 33.83 -83.54 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1318 DISTANCE = 6.50 ANGSTROMS REMARK 525 HOH A1319 DISTANCE = 7.51 ANGSTROMS REMARK 525 HOH B 904 DISTANCE = 5.87 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 7T7 A 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 902 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 903 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 904 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 7T7 B 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 504 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5U2N RELATED DB: PDB DBREF 5U2M A 9 485 UNP P43490 NAMPT_HUMAN 9 485 DBREF 5U2M B 9 485 UNP P43490 NAMPT_HUMAN 9 485 SEQRES 1 A 477 PHE ASN ILE LEU LEU ALA THR ASP SER TYR LYS VAL THR SEQRES 2 A 477 HIS TYR LYS GLN TYR PRO PRO ASN THR SER LYS VAL TYR SEQRES 3 A 477 SER TYR PHE GLU CYS ARG GLU LYS LYS THR GLU ASN SER SEQRES 4 A 477 LYS LEU ARG LYS VAL LYS TYR GLU GLU THR VAL PHE TYR SEQRES 5 A 477 GLY LEU GLN TYR ILE LEU ASN LYS TYR LEU LYS GLY LYS SEQRES 6 A 477 VAL VAL THR LYS GLU LYS ILE GLN GLU ALA LYS ASP VAL SEQRES 7 A 477 TYR LYS GLU HIS PHE GLN ASP ASP VAL PHE ASN GLU LYS SEQRES 8 A 477 GLY TRP ASN TYR ILE LEU GLU LYS TYR ASP GLY HIS LEU SEQRES 9 A 477 PRO ILE GLU ILE LYS ALA VAL PRO GLU GLY PHE VAL ILE SEQRES 10 A 477 PRO ARG GLY ASN VAL LEU PHE THR VAL GLU ASN THR ASP SEQRES 11 A 477 PRO GLU CYS TYR TRP LEU THR ASN TRP ILE GLU THR ILE SEQRES 12 A 477 LEU VAL GLN SER TRP TYR PRO ILE THR VAL ALA THR ASN SEQRES 13 A 477 SER ARG GLU GLN LYS LYS ILE LEU ALA LYS TYR LEU LEU SEQRES 14 A 477 GLU THR SER GLY ASN LEU ASP GLY LEU GLU TYR LYS LEU SEQRES 15 A 477 HIS ASP PHE GLY TYR ARG GLY VAL SER SER GLN GLU THR SEQRES 16 A 477 ALA GLY ILE GLY ALA SER ALA HIS LEU VAL ASN PHE LYS SEQRES 17 A 477 GLY THR ASP THR VAL ALA GLY LEU ALA LEU ILE LYS LYS SEQRES 18 A 477 TYR TYR GLY THR LYS ASP PRO VAL PRO GLY TYR SER VAL SEQRES 19 A 477 PRO ALA ALA GLU HIS SER THR ILE THR ALA TRP GLY LYS SEQRES 20 A 477 ASP HIS GLU LYS ASP ALA PHE GLU HIS ILE VAL THR GLN SEQRES 21 A 477 PHE SER SER VAL PRO VAL SER VAL VAL SER ASP SER TYR SEQRES 22 A 477 ASP ILE TYR ASN ALA CYS GLU LYS ILE TRP GLY GLU ASP SEQRES 23 A 477 LEU ARG HIS LEU ILE VAL SER ARG SER THR GLN ALA PRO SEQRES 24 A 477 LEU ILE ILE ARG PRO ASP SER GLY ASN PRO LEU ASP THR SEQRES 25 A 477 VAL LEU LYS VAL LEU GLU ILE LEU GLY LYS LYS PHE PRO SEQRES 26 A 477 VAL THR GLU ASN SER LYS GLY TYR LYS LEU LEU PRO PRO SEQRES 27 A 477 TYR LEU ARG VAL ILE GLN GLY ASP GLY VAL ASP ILE ASN SEQRES 28 A 477 THR LEU GLN GLU ILE VAL GLU GLY MET LYS GLN LYS MET SEQRES 29 A 477 TRP SER ILE GLU ASN ILE ALA PHE GLY SER GLY GLY GLY SEQRES 30 A 477 LEU LEU GLN LYS LEU THR ARG ASP LEU LEU ASN CYS SER SEQRES 31 A 477 PHE LYS CYS SER TYR VAL VAL THR ASN GLY LEU GLY ILE SEQRES 32 A 477 ASN VAL PHE LYS ASP PRO VAL ALA ASP PRO ASN LYS ARG SEQRES 33 A 477 SER LYS LYS GLY ARG LEU SER LEU HIS ARG THR PRO ALA SEQRES 34 A 477 GLY ASN PHE VAL THR LEU GLU GLU GLY LYS GLY ASP LEU SEQRES 35 A 477 GLU GLU TYR GLY GLN ASP LEU LEU HIS THR VAL PHE LYS SEQRES 36 A 477 ASN GLY LYS VAL THR LYS SER TYR SER PHE ASP GLU ILE SEQRES 37 A 477 ARG LYS ASN ALA GLN LEU ASN ILE GLU SEQRES 1 B 477 PHE ASN ILE LEU LEU ALA THR ASP SER TYR LYS VAL THR SEQRES 2 B 477 HIS TYR LYS GLN TYR PRO PRO ASN THR SER LYS VAL TYR SEQRES 3 B 477 SER TYR PHE GLU CYS ARG GLU LYS LYS THR GLU ASN SER SEQRES 4 B 477 LYS LEU ARG LYS VAL LYS TYR GLU GLU THR VAL PHE TYR SEQRES 5 B 477 GLY LEU GLN TYR ILE LEU ASN LYS TYR LEU LYS GLY LYS SEQRES 6 B 477 VAL VAL THR LYS GLU LYS ILE GLN GLU ALA LYS ASP VAL SEQRES 7 B 477 TYR LYS GLU HIS PHE GLN ASP ASP VAL PHE ASN GLU LYS SEQRES 8 B 477 GLY TRP ASN TYR ILE LEU GLU LYS TYR ASP GLY HIS LEU SEQRES 9 B 477 PRO ILE GLU ILE LYS ALA VAL PRO GLU GLY PHE VAL ILE SEQRES 10 B 477 PRO ARG GLY ASN VAL LEU PHE THR VAL GLU ASN THR ASP SEQRES 11 B 477 PRO GLU CYS TYR TRP LEU THR ASN TRP ILE GLU THR ILE SEQRES 12 B 477 LEU VAL GLN SER TRP TYR PRO ILE THR VAL ALA THR ASN SEQRES 13 B 477 SER ARG GLU GLN LYS LYS ILE LEU ALA LYS TYR LEU LEU SEQRES 14 B 477 GLU THR SER GLY ASN LEU ASP GLY LEU GLU TYR LYS LEU SEQRES 15 B 477 HIS ASP PHE GLY TYR ARG GLY VAL SER SER GLN GLU THR SEQRES 16 B 477 ALA GLY ILE GLY ALA SER ALA HIS LEU VAL ASN PHE LYS SEQRES 17 B 477 GLY THR ASP THR VAL ALA GLY LEU ALA LEU ILE LYS LYS SEQRES 18 B 477 TYR TYR GLY THR LYS ASP PRO VAL PRO GLY TYR SER VAL SEQRES 19 B 477 PRO ALA ALA GLU HIS SER THR ILE THR ALA TRP GLY LYS SEQRES 20 B 477 ASP HIS GLU LYS ASP ALA PHE GLU HIS ILE VAL THR GLN SEQRES 21 B 477 PHE SER SER VAL PRO VAL SER VAL VAL SER ASP SER TYR SEQRES 22 B 477 ASP ILE TYR ASN ALA CYS GLU LYS ILE TRP GLY GLU ASP SEQRES 23 B 477 LEU ARG HIS LEU ILE VAL SER ARG SER THR GLN ALA PRO SEQRES 24 B 477 LEU ILE ILE ARG PRO ASP SER GLY ASN PRO LEU ASP THR SEQRES 25 B 477 VAL LEU LYS VAL LEU GLU ILE LEU GLY LYS LYS PHE PRO SEQRES 26 B 477 VAL THR GLU ASN SER LYS GLY TYR LYS LEU LEU PRO PRO SEQRES 27 B 477 TYR LEU ARG VAL ILE GLN GLY ASP GLY VAL ASP ILE ASN SEQRES 28 B 477 THR LEU GLN GLU ILE VAL GLU GLY MET LYS GLN LYS MET SEQRES 29 B 477 TRP SER ILE GLU ASN ILE ALA PHE GLY SER GLY GLY GLY SEQRES 30 B 477 LEU LEU GLN LYS LEU THR ARG ASP LEU LEU ASN CYS SER SEQRES 31 B 477 PHE LYS CYS SER TYR VAL VAL THR ASN GLY LEU GLY ILE SEQRES 32 B 477 ASN VAL PHE LYS ASP PRO VAL ALA ASP PRO ASN LYS ARG SEQRES 33 B 477 SER LYS LYS GLY ARG LEU SER LEU HIS ARG THR PRO ALA SEQRES 34 B 477 GLY ASN PHE VAL THR LEU GLU GLU GLY LYS GLY ASP LEU SEQRES 35 B 477 GLU GLU TYR GLY GLN ASP LEU LEU HIS THR VAL PHE LYS SEQRES 36 B 477 ASN GLY LYS VAL THR LYS SER TYR SER PHE ASP GLU ILE SEQRES 37 B 477 ARG LYS ASN ALA GLN LEU ASN ILE GLU HET 7T7 A 901 27 HET SO4 A 902 5 HET SO4 A 903 5 HET SO4 A 904 5 HET 7T7 B 501 27 HET SO4 B 502 5 HET SO4 B 503 5 HET SO4 B 504 5 HETNAM 7T7 N-[4-({[(3S)-OXOLAN-3-YL]METHYL}CARBAMOYL)PHENYL]-1,3- HETNAM 2 7T7 DIHYDRO-2H-ISOINDOLE-2-CARBOXAMIDE HETNAM SO4 SULFATE ION FORMUL 3 7T7 2(C21 H23 N3 O3) FORMUL 4 SO4 6(O4 S 2-) FORMUL 11 HOH *623(H2 O) HELIX 1 AA1 ASN A 10 ALA A 14 5 5 HELIX 2 AA2 ASP A 16 GLN A 25 5 10 HELIX 3 AA3 GLY A 61 LEU A 70 1 10 HELIX 4 AA4 THR A 76 GLN A 92 1 17 HELIX 5 AA5 ASN A 97 ASP A 109 1 13 HELIX 6 AA6 ASP A 138 TYR A 142 5 5 HELIX 7 AA7 TRP A 143 ILE A 148 1 6 HELIX 8 AA8 ILE A 148 GLN A 154 1 7 HELIX 9 AA9 SER A 155 GLY A 181 1 27 HELIX 10 AB1 GLY A 185 TYR A 188 5 4 HELIX 11 AB2 SER A 200 LEU A 212 1 13 HELIX 12 AB3 VAL A 221 TYR A 231 1 11 HELIX 13 AB4 GLU A 246 ALA A 252 1 7 HELIX 14 AB5 TRP A 253 ASP A 256 5 4 HELIX 15 AB6 HIS A 257 PHE A 269 1 13 HELIX 16 AB7 ASP A 282 LYS A 289 1 8 HELIX 17 AB8 LEU A 295 VAL A 300 1 6 HELIX 18 AB9 ASN A 316 PHE A 332 1 17 HELIX 19 AC1 ASP A 357 LYS A 371 1 15 HELIX 20 AC2 SER A 374 GLU A 376 5 3 HELIX 21 AC3 GLY A 383 GLN A 388 1 6 HELIX 22 AC4 ASP A 420 ARG A 424 5 5 HELIX 23 AC5 GLY A 446 LEU A 450 5 5 HELIX 24 AC6 SER A 472 ALA A 480 1 9 HELIX 25 AC7 ASN B 10 ALA B 14 5 5 HELIX 26 AC8 ASP B 16 GLN B 25 5 10 HELIX 27 AC9 GLY B 61 LEU B 70 1 10 HELIX 28 AD1 THR B 76 PHE B 91 1 16 HELIX 29 AD2 ASN B 97 ASP B 109 1 13 HELIX 30 AD3 ASP B 138 TYR B 142 5 5 HELIX 31 AD4 TRP B 143 ILE B 148 1 6 HELIX 32 AD5 ILE B 148 GLN B 154 1 7 HELIX 33 AD6 SER B 155 SER B 180 1 26 HELIX 34 AD7 GLY B 185 TYR B 188 5 4 HELIX 35 AD8 GLY B 194 VAL B 198 5 5 HELIX 36 AD9 SER B 200 LEU B 212 1 13 HELIX 37 AE1 VAL B 221 TYR B 231 1 11 HELIX 38 AE2 GLU B 246 ALA B 252 1 7 HELIX 39 AE3 TRP B 253 ASP B 256 5 4 HELIX 40 AE4 HIS B 257 PHE B 269 1 13 HELIX 41 AE5 ASP B 282 LYS B 289 1 8 HELIX 42 AE6 LEU B 295 VAL B 300 1 6 HELIX 43 AE7 ASN B 316 PHE B 332 1 17 HELIX 44 AE8 ASP B 357 LYS B 371 1 15 HELIX 45 AE9 SER B 374 GLU B 376 5 3 HELIX 46 AF1 GLY B 383 GLN B 388 1 6 HELIX 47 AF2 ASP B 420 ARG B 424 5 5 HELIX 48 AF3 GLY B 446 GLY B 454 5 9 HELIX 49 AF4 SER B 472 GLN B 481 1 10 SHEET 1 AA1 7 LEU A 409 ASN A 412 0 SHEET 2 AA1 7 CYS A 397 THR A 406 -1 N VAL A 404 O ILE A 411 SHEET 3 AA1 7 THR A 30 CYS A 39 -1 N TYR A 34 O TYR A 403 SHEET 4 AA1 7 PHE A 132 ASN A 136 -1 O VAL A 134 N SER A 35 SHEET 5 AA1 7 ILE A 114 ALA A 118 -1 N GLU A 115 O GLU A 135 SHEET 6 AA1 7 HIS A 459 LYS A 463 -1 O VAL A 461 N ILE A 116 SHEET 7 AA1 7 LYS A 466 VAL A 467 -1 O LYS A 466 N LYS A 463 SHEET 1 AA2 2 GLU A 56 VAL A 58 0 SHEET 2 AA2 2 VAL A 124 PRO A 126 -1 O ILE A 125 N THR A 57 SHEET 1 AA3 5 LEU A 190 ASP A 192 0 SHEET 2 AA3 5 ILE A 378 SER A 382 1 O PHE A 380 N HIS A 191 SHEET 3 AA3 5 LEU A 348 GLN A 352 1 N GLN A 352 O GLY A 381 SHEET 4 AA3 5 LEU A 308 ARG A 311 1 N LEU A 308 O ARG A 349 SHEET 5 AA3 5 VAL A 274 VAL A 277 1 N VAL A 274 O ILE A 309 SHEET 1 AA4 2 THR A 335 GLU A 336 0 SHEET 2 AA4 2 LYS A 342 LEU A 343 -1 O LEU A 343 N THR A 335 SHEET 1 AA5 2 SER A 431 ARG A 434 0 SHEET 2 AA5 2 PHE A 440 LEU A 443 -1 O VAL A 441 N HIS A 433 SHEET 1 AA6 7 LEU B 409 ASN B 412 0 SHEET 2 AA6 7 CYS B 397 THR B 406 -1 N VAL B 404 O ILE B 411 SHEET 3 AA6 7 THR B 30 CYS B 39 -1 N TYR B 34 O TYR B 403 SHEET 4 AA6 7 VAL B 130 ASN B 136 -1 O VAL B 134 N SER B 35 SHEET 5 AA6 7 ILE B 114 ALA B 118 -1 N GLU B 115 O GLU B 135 SHEET 6 AA6 7 HIS B 459 LYS B 463 -1 O VAL B 461 N ILE B 116 SHEET 7 AA6 7 LYS B 466 VAL B 467 -1 O LYS B 466 N LYS B 463 SHEET 1 AA7 2 GLU B 56 VAL B 58 0 SHEET 2 AA7 2 VAL B 124 PRO B 126 -1 O ILE B 125 N THR B 57 SHEET 1 AA8 5 LEU B 190 ASP B 192 0 SHEET 2 AA8 5 ILE B 378 SER B 382 1 O PHE B 380 N HIS B 191 SHEET 3 AA8 5 LEU B 348 GLN B 352 1 N GLN B 352 O GLY B 381 SHEET 4 AA8 5 LEU B 308 ARG B 311 1 N ILE B 310 O ARG B 349 SHEET 5 AA8 5 VAL B 274 VAL B 277 1 N VAL B 274 O ILE B 309 SHEET 1 AA9 2 THR B 335 GLU B 336 0 SHEET 2 AA9 2 LYS B 342 LEU B 343 -1 O LEU B 343 N THR B 335 SHEET 1 AB1 2 SER B 431 ARG B 434 0 SHEET 2 AB1 2 PHE B 440 LEU B 443 -1 O VAL B 441 N HIS B 433 SITE 1 AC1 18 TYR A 188 HIS A 191 PHE A 193 ARG A 196 SITE 2 AC1 18 ASP A 219 VAL A 242 ALA A 244 PRO A 273 SITE 3 AC1 18 SER A 275 ILE A 309 ARG A 311 ILE A 351 SITE 4 AC1 18 ALA A 379 SO4 A 902 HOH A1085 HOH A1129 SITE 5 AC1 18 HOH A1177 TYR B 18 SITE 1 AC2 10 ARG A 196 GLU A 246 HIS A 247 ARG A 311 SITE 2 AC2 10 ASP A 313 7T7 A 901 HOH A1005 HOH A1156 SITE 3 AC2 10 TYR B 18 HOH B 643 SITE 1 AC3 5 ARG A 392 SER A 398 LYS A 400 HOH A1027 SITE 2 AC3 5 HOH A1181 SITE 1 AC4 7 ARG A 392 HOH A1064 HOH A1176 GLY B 197 SITE 2 AC4 7 GLY B 383 GLY B 384 HOH B 615 SITE 1 AC5 16 TYR A 18 TYR B 188 HIS B 191 PHE B 193 SITE 2 AC5 16 ARG B 196 ASP B 219 VAL B 242 ALA B 244 SITE 3 AC5 16 PRO B 273 SER B 275 ILE B 309 ARG B 311 SITE 4 AC5 16 ILE B 351 ALA B 379 HOH B 716 HOH B 735 SITE 1 AC6 5 ARG A 196 ARG B 40 ARG B 392 SER B 398 SITE 2 AC6 5 LYS B 400 SITE 1 AC7 7 GLY A 197 GLY A 383 GLY A 384 ARG B 392 SITE 2 AC7 7 ASP B 393 HOH B 608 HOH B 662 SITE 1 AC8 10 TYR A 18 HOH A1027 HOH A1065 ARG B 196 SITE 2 AC8 10 GLU B 246 HIS B 247 ARG B 311 ASP B 313 SITE 3 AC8 10 HOH B 687 HOH B 787 CRYST1 60.978 106.611 83.122 90.00 96.64 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016399 0.000000 0.001909 0.00000 SCALE2 0.000000 0.009380 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012112 0.00000